Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 8869169Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Internal Medicine
NIH Funding · FY2025
Linked Award Amount
$562.8K
Full award amounts, FY2025
Award Records
1
Records listing this PI
Award-Linked Rank
#29,342
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing Jianhua Yu as a PI. Multi-PI records show the full award amount for context.
- 5R01CA266457-04R01Phase 1 Evaluation of Enhanced Natural Killer Cells as a Treatment Strategy in Non-Small cell Lung Cancer Patients Refractory to PD-1/PD-L1 Immune Checkpoint Inhibitors$562.8Kaward amount
Award organization
Organizations that administered FY2025 awards listing Jianhua Yu as a PI.
FY2025 award administered by University of California-Irvine (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUniversity of California-Irvine
- 2025$500K Cumulative Funding
- 2025R01 Grant Holder
- 2026$1M Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Jianhua Yu.